AI-for-COVID19 Imaging Archive Platform Enables Sharing of Radiographic Images from COVID-19 Patients and Development of AI Solutions

By HospiMedica International staff writers
Posted on 18 May 2021
The "AIforCOVID Imaging Archive" platform promoted and implemented by Bracco Imaging (Milan, Italy) in partnership with the Centro Diagnostico Italiano (Milan, Italy) enables the sharing of radiographic images from COVID-19 patients and development of leading-edge artificial intelligence (AI)-based methods for predicting clinical developments of the disease caused by SARS-CoV-2.

The AIforCOVID Imaging Archive is a shared collection of images and clinical data for developing innovative AI-based methods to predict clinical developments of SARS-CoV-2-related disease. The valuable tool enables the international scientific community to share radiological and clinical data and find innovative solutions to combat the disease. The AIforCOVID Imaging Archive, which is available, open access to the global scientific community, contains more than a thousand positive patient chest radiographic examinations carried out upon hospitalization. Each X-ray is associated with clinical information about the patient collected at that time.

Image: AIforCOVID Imaging Archive (Photo courtesy of Bracco Imaging)

Data was collected as part of the "AIforCOVID" no-profit multicentre research project, promoted by Bracco and Centro Diagnostico Italiano in partnership with major Italian hospitals and public and private research institutes. The AI algorithms have the objective of identifying indicators of risk of a severe disease progression, providing physicians with a tool to evaluate the potential need for intensive therapy ahead of time. The platform integrates a range of Amazon Web Services technologies, including machine learning and AI from Amazon SageMaker, a fully managed service for creating, training and deploying machine learning models.

"We are very proud of this initiative and the collaborations that have been established with important Italian hospitals and research centers," said Fulvio Renoldi Bracco, CEO Bracco Imaging SpA. "We are witnessing the age of personalized healthcare where partnership between Industry and providers will play a crucial role as enabler of knowledge sharing and value creation. In this case, the application of Artificial Intelligence technology to imaging data empowers Clinicians with a tool to predict COVID-19 disease progression and, more importantly, allows for more targeted and timely intervention."

Related Links:
Bracco Imaging
Centro Diagnostico Italiano



Latest COVID-19 News